Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
02/19/2014 | CN102875648B Method for preparing telaprevir |
02/19/2014 | CN102807609B Polypeptide for preventing and/or treating pain and application of polypeptide |
02/19/2014 | CN102464702B Method for preparing leuprorelin acetate, product and application |
02/19/2014 | CN102241740B Compounds with thrombolytic activities and preparation methods and applications thereof |
02/18/2014 | US8653238 Compositions and methods for transport of molecules with enhanced release properties across biological barriers |
02/18/2014 | US8653237 Peptide analogues |
02/18/2014 | US8653236 Therapeutic agents |
02/18/2014 | US8653235 Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
02/18/2014 | US8653038 HLA-A* 1101-restricted WT1 peptide and pharmaceutical composition comprising the same |
02/18/2014 | US8653030 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
02/18/2014 | US8652485 Peptide for vaccine |
02/18/2014 | US8652457 Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection |
02/18/2014 | CA2708753C Peptide diagnostic agent for lyme disease |
02/18/2014 | CA2688574C Cyclic peptide cxcr4 antagonists |
02/18/2014 | CA2544820C Bacterial expression of protease inhibitors and variants thereof |
02/18/2014 | CA2451741C Peyers's patch and/or m-celle targeting ligands |
02/13/2014 | WO2014025890A1 Drug delivery vehicle comprising conjugates between targeting polyamino acids and fatty acids |
02/13/2014 | WO2014024914A1 Peptide library and use thereof |
02/13/2014 | WO2014023766A1 Combinations with a backbone-cyclized peptide |
02/13/2014 | WO2014023757A1 Combinations with a backbone-cyclized peptide |
02/13/2014 | WO2014023129A1 α-CONOTOXIN PEPTIDE, AND MEDICAL COMPOSITION AND PURPOSE THEREOF |
02/13/2014 | WO2014023007A1 Use of pedf-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis |
02/13/2014 | WO2013192430A3 Dynamic biomimetic synzyme catalyst, catalysis, and catalytic systems |
02/13/2014 | US20140045771 Novel dipeptidyl peptidase iv (dp-iv) compounds |
02/13/2014 | US20140045769 Hydrogen bond surrogate macrocycles as modulators of ras |
02/13/2014 | US20140045768 Tight Junction Protein Modulators and Uses Thereof |
02/13/2014 | US20140045750 Methods of protecting against apoptosis using lipopeptides |
02/13/2014 | US20140045747 Methods for increasing and mobilizing hematopoietic stem cells |
02/13/2014 | US20140045247 Fusion protein |
02/13/2014 | US20140044754 Tdf-related compounds and analogs thereof |
02/13/2014 | US20140044725 Alzheimer's disease treatment method |
02/13/2014 | US20140044686 Molecular marker for cancer stem cell |
02/13/2014 | US20140044655 Novel activator peptides for synthesizing extracellular matrix proteins, and cosmetic compositions including same |
02/13/2014 | US20140044649 Beta sheet tapes ribbons in tissue engineering |
02/12/2014 | EP2695895A1 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
02/12/2014 | EP2695891A1 Octapeptide, radiopharmaceutical agent based thereon and method for diagnosing tumors |
02/12/2014 | EP2694654A1 Protease cleavage site peptides as an hiv vaccine |
02/12/2014 | EP2694531A1 Methods for manufacturing an antifungal agent |
02/12/2014 | EP2694530A1 Novel peptides that bind to types of mhc class ii and their use on diagnosis and treatment |
02/12/2014 | EP2694529A2 Cell penetrating peptides for intracellular delivery of molecules |
02/12/2014 | CN103582649A Novel activator peptides for synthesizing extracellular matrix proteins, and cosmetic compositions including same |
02/12/2014 | CN103571728A Use of lipopeptide compounds for improving sweet smell of white spirit and determination method of lipopeptide compounds |
02/12/2014 | CN103570808A Alpha-conotoxin peptide TxIB/Txd4, as well as pharmaceutical composition and use thereof |
02/12/2014 | CN103570807A Short peptide, preparation method thereof, and applications of the short peptide in diagnosis or treatment of apoA-I related diseases |
02/12/2014 | CN103570806A 多肽环氧酮化合物 Peptide epoxy ketone compound |
02/12/2014 | CN103570805A Active polypeptide and application of active polypeptide in plant root growth |
02/12/2014 | CN103570605A Telaprevir and preparation method of telaprevir intermediate |
02/12/2014 | CN102911257B Cyclic lipopeptide antibiotic and preparation and application thereof |
02/12/2014 | CN102010461B Alpha spiral cation polypeptide molecule and preparation method and application thereof |
02/11/2014 | US8648170 Peptide-presenting surfaces for long-term culture of pluripotent cells |
02/11/2014 | US8648046 Compositions and methods for visualizing and eliminating cancer stem cells |
02/11/2014 | US8648042 Pharmaceutical compositions |
02/11/2014 | US8647826 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
02/11/2014 | US8647630 Mite allergen |
02/11/2014 | US8647628 Peptide epitopes of apolipoprotein B |
02/11/2014 | CA2529496C Anti-cd74 immunoconjugates and methods |
02/06/2014 | WO2014022271A1 Method of treating metastatic cancer |
02/06/2014 | WO2014021389A1 Peptide capable of inhibiting mate activity |
02/06/2014 | WO2014019520A1 Tumor vessel specific binding polypeptide and application thereof |
02/06/2014 | WO2013105089A8 Anti-inflammatory peptides and use thereof |
02/06/2014 | US20140039155 Amyloid-beta peptide crystal structure |
02/06/2014 | US20140038909 Tissue occluding agent |
02/06/2014 | US20140038902 Method of Treating Metastatic Cancer |
02/06/2014 | US20140038898 Peptides for suppressing inflammation |
02/06/2014 | US20140038886 Hydrophobic modified peptides and their use for liver specific targeting |
02/06/2014 | US20140038880 Compositions and Methods for Promoting Wound Healing and Tissue Regeneration |
02/06/2014 | US20140037666 Compositions for preventing and/or treating an infection by an hiv-1 virus |
02/06/2014 | US20140037637 Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4) |
02/06/2014 | US20140037626 Metal Abstraction Peptide With Release of Metal |
02/06/2014 | US20140037623 Pharmaceutical Compositions Comprising Antibodies Binding To EBV (Ebstein-Barr Virus) Protein BARF1 |
02/06/2014 | US20140037593 Tricalcium Phosphate Binding Peptides And Uses Thereof |
02/05/2014 | EP2691105A1 Methods and compositions related to inhibition of viral entry |
02/05/2014 | CN103562444A Diagnostic and treatment methods using a ligand library |
02/05/2014 | CN103555622A Bacillus marinus S-1 and anti-tumor active polypeptide produced thereby |
02/05/2014 | CN103554265A Solid-phase synthesis method for gonadotropin-releasing hormone (GnRH) castration vaccine |
02/05/2014 | CN103554230A Amphomycin-type compounds and preparation method thereof |
02/05/2014 | CN103554229A Solid-phase synthesis method for Buserelin |
02/05/2014 | CN103554228A GnRH (gonadotropin-releasing hormone) castrated vaccine as well as parallel body |
02/05/2014 | CN103554227A Polypeptide and use thereof |
02/05/2014 | CN103554226A All solid phase synthesis method for alpha-conotoxin MI |
02/05/2014 | CN103554225A Synthetic antibacterial peptides and application thereof |
02/05/2014 | CN103554224A Telaprevir preparation method |
02/05/2014 | CN103554223A Short peptide for increasing thermal stability of transglutaminase, and application thereof |
02/05/2014 | CN103554222A Compounds for enzyme inhibition |
02/05/2014 | CN102675424B Polypeptide drug for resisting Hepatitis B virus X protein |
02/05/2014 | CN102675423B Polypeptide medicine against hepatitis B virus X protein |
02/05/2014 | CN102675422B Polypeptide drug against hepatitis B virus X protein (HBx) |
02/05/2014 | CN102659928B Synthetic signal peptide and application thereof |
02/05/2014 | CN102659927B Synthetic signal peptide and application thereof |
02/04/2014 | US8642726 Peptide epitopes of apolipoprotein B |
02/04/2014 | US8642725 Process for production of peptide thioester |
02/04/2014 | US8642561 Peptides whose uptake by cells is controllable |
02/04/2014 | US8642559 C-terminal domain truncation of mGluR1α by calpain and uses thereof |
02/04/2014 | US8642558 Methods, systems, and compositions for calpain inhabition |
02/04/2014 | US8642536 Method of making biologically active alpha-beta peptides |
02/04/2014 | US8642535 Short fatty acid tail polymyxin derivatives and uses thereof |
02/04/2014 | US8642048 Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
02/04/2014 | US8642043 Peptide epitopes of apolipoprotein B |
02/04/2014 | US8642010 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
02/04/2014 | CA2727642C Synthesis of cyclosporin analogs |